摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-氟-5-碘嘧啶 | 697300-79-1

中文名称
2-氟-5-碘嘧啶
中文别名
——
英文名称
2-fluoro-5-iodopyrimidine
英文别名
——
2-氟-5-碘嘧啶化学式
CAS
697300-79-1
化学式
C4H2FIN2
mdl
——
分子量
223.976
InChiKey
IQFADBWJBWUPMH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.3
  • 重原子数:
    8
  • 可旋转键数:
    0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    25.8
  • 氢给体数:
    0
  • 氢受体数:
    3

安全信息

  • 危险性防范说明:
    P280,P305+P351+P338,P310
  • 危险性描述:
    H302,H315,H319,H332,H335

反应信息

  • 作为反应物:
    描述:
    1,3-dioxoisoindolin-2-yl benzoylalaninate 、 2-氟-5-碘嘧啶 、 nickel(II) tetrafluoroborate hexahydrate 、 C34H50N4 作用下, 以 四氢呋喃 为溶剂, 以54 %的产率得到(R)-N-(1-(2-fluoropyrimidin-5-yl)ethyl)benzamide
    参考文献:
    名称:
    镍催化 α-氨基酸 NHP 酯不对称脱羧芳基化生成手性苄胺
    摘要:
    已经建立了镍催化的 NHP 酯通过还原交叉偶联的不对称脱羧基反应。利用氨基酸酯的 NHP 作为自由基前体提供了一种新的方案,其中可以获得结构多样的手性苄胺。该方法具有优异的催化效率、高对映选择性控制、温和的条件和良好的官能团耐受性,从而能够实现生物活性分子和药物的后期修饰。
    DOI:
    10.1021/acs.orglett.3c02431
  • 作为产物:
    描述:
    2-氨基-5-碘嘧啶,吡啶氢氟酸 、 sodium nitrite 作用下, 反应 1.5h, 以72%的产率得到2-氟-5-碘嘧啶
    参考文献:
    名称:
    5-Substituted Derivatives of 6-Halogeno-3-((2-(S)-azetidinyl)methoxy)pyridine and 6-Halogeno-3-((2-(S)-pyrrolidinyl)methoxy)pyridine with Low Picomolar Affinity for α4β2 Nicotinic Acetylcholine Receptor and Wide Range of Lipophilicity:  Potential Probes for Imaging with Positron Emission Tomography
    摘要:
    Potential positron emission tomography (PET) ligands with low picomolar affinity at the nicotinic acetylcholine receptor (nAChR) and with lipophilicity (log D) ranging from -1.6 to +1.5 have been synthesized. Most members of the series, which are derivatives of 5-substituted-6-halogeno-A-85380, exhibited a higher binding affinity at alpha4beta2-nAChRs than epibatidine. An analysis, by molecular modeling, revealed an important role of the orientation of the additional heterocyclic ring on the binding affinity of the ligands with nAChRs. The existing nicotinic pharmacophore models do not accommodate this finding. Two compounds of the series, 6-[F-18]-fluoro-5-(pyridin-3-yl)-A-85380 ([F-18]31) and 6-chloro-3-((2-(S)-azetidinyl)methoxy)-5-(2- [F-18]-fluoropyridin-5-yl)pyridine) ([F-18]35), were radiolabeled with F-18. Comparison of PET data for [F-18]31 and 2-[F-18]FA shows the influence of lipophilicity on the binding potential. Our recent PET studies with [F-18]35 demonstrated that its binding potential values in Rhesus monkey brain were ca. 2.5 times those of 2-[F-18]FA. Therefore, [F-18]35 and several other members of the series, when radiolabeled, will be suitable for quantitative imaging of extrathalamic nAChRs.
    DOI:
    10.1021/jm030432v
点击查看最新优质反应信息

文献信息

  • Discovery of 2-(4-sulfonamidophenyl)-indole 3-carboxamides as potent and selective inhibitors with broad hepatitis C virus genotype activity targeting HCV NS4B
    作者:Nanjing Zhang、Anthony Turpoff、Xiaoyan Zhang、Song Huang、Yalei Liu、Neil Almstead、F. George Njoroge、Zhengxian Gu、Jason Graci、Stephen P. Jung、John Pichardo、Joseph Colacino、Fred Lahser、Paul Ingravallo、Marla Weetall、Amin Nomeir、Gary M. Karp
    DOI:10.1016/j.bmcl.2015.11.065
    日期:2016.1
    A novel series of 2-(4-sulfonamidophenyl)-indole 3-carboxamides was identified and optimized for activity against the HCV genotype 1b replicon resulting in compounds with potent and selective activity. Further evaluation of this series demonstrated potent activity across HCV genotypes 1a, 2a and 3a. Compound 4z had reduced activity against HCV genotype 1b replicons containing single mutations in the NS4B coding sequence (F98C and V105M) indicating that NS4B is the target. This novel series of 2-(4-sulfonamidophenyl)-indole 3-carboxamides serves as a promising starting point for a pan-genotype HCV discovery program. (C) 2015 Elsevier Ltd. All rights reserved.
  • Simplifying Access to Targeted Protein Degraders via Nickel Electrocatalytic Cross‐Coupling
    作者:Philipp Neigenfind、Luca Massaro、Áron Péter、Andrew P. Degnan、Megan A. Emmanuel、Martins S. Oderinde、Chi He、David Peters、Tamara El‐Hayek Ewing、Yu Kawamata、Phil S. Baran
    DOI:10.1002/anie.202319856
    日期:2024.4.15
    Abstract

    C−C linked glutarimide‐containing structures with direct utility in the preparation of cereblon‐based degraders (PROTACs, CELMoDs) can be assessed in a single step from inexpensive, commercial α‐bromoglutarimide through a unique Brønsted‐acid assisted Ni‐electrocatalytic approach. The reaction tolerates a broad array of functional groups that are historically problematic and can be applied to the simplified synthesis of dozens of known compounds that have only been procured through laborious, wasteful, multi‐step sequences. The reaction is scalable in both batch and flow and features a trivial procedure wherein the most time‐consuming aspect of reaction setup is weighing out the starting materials.

  • 5-Substituted Derivatives of 6-Halogeno-3-((2-(<i>S</i>)-azetidinyl)methoxy)pyridine and 6-Halogeno-3-((2-(<i>S</i>)-pyrrolidinyl)methoxy)pyridine with Low Picomolar Affinity for α4β2 Nicotinic Acetylcholine Receptor and Wide Range of Lipophilicity:  Potential Probes for Imaging with Positron Emission Tomography
    作者:Yi Zhang、Olga A. Pavlova、Svetlana I. Chefer、Andrew W. Hall、Varughese Kurian、LaVerne L. Brown、Alane S. Kimes、Alexey G. Mukhin、Andrew G. Horti
    DOI:10.1021/jm030432v
    日期:2004.5.1
    Potential positron emission tomography (PET) ligands with low picomolar affinity at the nicotinic acetylcholine receptor (nAChR) and with lipophilicity (log D) ranging from -1.6 to +1.5 have been synthesized. Most members of the series, which are derivatives of 5-substituted-6-halogeno-A-85380, exhibited a higher binding affinity at alpha4beta2-nAChRs than epibatidine. An analysis, by molecular modeling, revealed an important role of the orientation of the additional heterocyclic ring on the binding affinity of the ligands with nAChRs. The existing nicotinic pharmacophore models do not accommodate this finding. Two compounds of the series, 6-[F-18]-fluoro-5-(pyridin-3-yl)-A-85380 ([F-18]31) and 6-chloro-3-((2-(S)-azetidinyl)methoxy)-5-(2- [F-18]-fluoropyridin-5-yl)pyridine) ([F-18]35), were radiolabeled with F-18. Comparison of PET data for [F-18]31 and 2-[F-18]FA shows the influence of lipophilicity on the binding potential. Our recent PET studies with [F-18]35 demonstrated that its binding potential values in Rhesus monkey brain were ca. 2.5 times those of 2-[F-18]FA. Therefore, [F-18]35 and several other members of the series, when radiolabeled, will be suitable for quantitative imaging of extrathalamic nAChRs.
  • Nickel-Catalyzed Asymmetric Decarboxyarylation with NHP Esters of α-Amino Acid to Chiral Benzylamines
    作者:Cheng-Yu Wang、Yu-Ling Huang、Wei-Cheng Xu、Qian Gao、Peng Liu、Yu-Xiang Bi、Guo-Kai Liu、Xi-Sheng Wang
    DOI:10.1021/acs.orglett.3c02431
    日期:2023.9.29
    A nickel-catalyzed asymmetric decarboxyarylation of NHP esters via reductive cross-coupling has been established. Utilizing the NHP of amino acid esters as radical precursors furnishes a new protocol in which structurally diverse chiral benzylamines could be accessible. This method has demonstrated excellent catalytic efficiency, high enantioselective control, mild conditions, and good functional group
    已经建立了镍催化的 NHP 酯通过还原交叉偶联的不对称脱羧基反应。利用氨基酸酯的 NHP 作为自由基前体提供了一种新的方案,其中可以获得结构多样的手性苄胺。该方法具有优异的催化效率、高对映选择性控制、温和的条件和良好的官能团耐受性,从而能够实现生物活性分子和药物的后期修饰。
查看更多